Insider Trading History of Valenzano Ken


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Valenzano Ken since year 2005. The trader's CIK number is 1492123. At the time of the last reporting, Valenzano Ken was the VP, Pharmacology & Biology of Amicus Therapeutics, Inc. . (stock ticker symbol FOLD). See this page for all insider trading activities at Amicus Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Valenzano Ken since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-07-13 FOLD Amicus Therapeutics, Inc. Option Ex 15,000 15.00 225,000
2015-07-13 FOLD Amicus Therapeutics, Inc. Sale 15,000 15.00 225,000
2015-06-22 FOLD Amicus Therapeutics, Inc. Option Ex 20,500 13.85 284,007
2015-06-22 FOLD Amicus Therapeutics, Inc. Sale 20,500 13.85 284,007
2015-05-11 FOLD Amicus Therapeutics, Inc. Sale 13,000 10.85 140,998
2015-05-08 FOLD Amicus Therapeutics, Inc. Option Ex 25,000 .00 0
2015-04-15 FOLD Amicus Therapeutics, Inc. Option Ex 5,000 12.50 62,500
2015-04-15 FOLD Amicus Therapeutics, Inc. Sale 5,000 12.50 62,500
2015-03-20 FOLD Amicus Therapeutics, Inc. Option Ex 6,043 11.68 70,558
2015-03-20 FOLD Amicus Therapeutics, Inc. Sale 7,751 11.89 92,182
2015-03-20 FOLD Amicus Therapeutics, Inc. Option Ex 13,050 11.53 150,505
2015-03-20 FOLD Amicus Therapeutics, Inc. Sale 13,050 11.53 150,505
2014-11-25 FOLD Amicus Therapeutics, Inc. Buy 25,000 8.00 200,000
2014-11-25 FOLD Amicus Therapeutics, Inc. Sale 25,000 8.00 200,000
2014-08-25 FOLD Amicus Therapeutics, Inc. Sale 12,450 6.00 74,700
2014-08-25 FOLD Amicus Therapeutics, Inc. Buy 12,450 6.00 74,700
2014-08-20 FOLD Amicus Therapeutics, Inc. Buy 7,000 5.40 37,800
2014-08-20 FOLD Amicus Therapeutics, Inc. Sale 7,000 5.40 37,800
2011-05-24 FOLD Amicus Therapeutics, Inc. Option Ex 2,250 .64 1,435
2011-05-24 FOLD Amicus Therapeutics, Inc. Sale 2,250 7.50 16,875

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Valenzano Ken (VP, Pharmacology & Biology of Amicus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.